2020
DOI: 10.1016/j.ejmg.2020.103843
|View full text |Cite
|
Sign up to set email alerts
|

CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 24 publications
0
10
0
Order By: Relevance
“…1 Title: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations Lance H. Rodan MD, 1,2 Rebecca C. Spillmann MS CGC, 3 Harley T. Kurata PhD, 4 Shawn M. Lamothe PhD, 4 Jasmine Maghera BS, 4 Rami Abou Jamra MD, 5 Anna Alkelai PhD, 6 Stylianos E. Antonarakis MD, DSc, 7 Isis Atallah MD, 8 Omer Bar-Yosef MD, PhD, 9,10 Frédéric Bilan PhD, 11 Kathrine Bjorgo MD, 12 Xavier Blanc PhD, 7 Patrick Van Bogaert MD, PhD, 13 Yoav Bolkier MD, 10,14 Lindsay C. Burrage MD, PhD, 15 Björn U. Christ MA, 16 Jorge L. Granadillo MD, 17 Patricia Dickson MD, 17 Kirsten A. Donald MBChB, PhD, 16 Christèle Dubourg PhD, 18,19 Aviva Eliyahu MD, 10,20,21 Lisa Emrick MD, 15 Kendra Engleman MS, CGC, 22 Michaela Veronika Gonfiantini MD, 23 Jean-Marc Good MD, PhD, 24 Judith Kalser MD, 25 Chiara Kloeckner CM, 5 Guus Lachmeijer MD, PhD, 26 Marina Macchiaiolo MD, 23 Francesco Nicita MD, 27 Sylvie Odent MD, 28 Emily O'Heir BS, 1,29 Xilma Ortiz-Gonzalez MD, PhD, 30 Marta Pacio-Miguez MS, 31 María Palomares-Bralo MSc, PhD, 31…”
mentioning
confidence: 99%
“…1 Title: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations Lance H. Rodan MD, 1,2 Rebecca C. Spillmann MS CGC, 3 Harley T. Kurata PhD, 4 Shawn M. Lamothe PhD, 4 Jasmine Maghera BS, 4 Rami Abou Jamra MD, 5 Anna Alkelai PhD, 6 Stylianos E. Antonarakis MD, DSc, 7 Isis Atallah MD, 8 Omer Bar-Yosef MD, PhD, 9,10 Frédéric Bilan PhD, 11 Kathrine Bjorgo MD, 12 Xavier Blanc PhD, 7 Patrick Van Bogaert MD, PhD, 13 Yoav Bolkier MD, 10,14 Lindsay C. Burrage MD, PhD, 15 Björn U. Christ MA, 16 Jorge L. Granadillo MD, 17 Patricia Dickson MD, 17 Kirsten A. Donald MBChB, PhD, 16 Christèle Dubourg PhD, 18,19 Aviva Eliyahu MD, 10,20,21 Lisa Emrick MD, 15 Kendra Engleman MS, CGC, 22 Michaela Veronika Gonfiantini MD, 23 Jean-Marc Good MD, PhD, 24 Judith Kalser MD, 25 Chiara Kloeckner CM, 5 Guus Lachmeijer MD, PhD, 26 Marina Macchiaiolo MD, 23 Francesco Nicita MD, 27 Sylvie Odent MD, 28 Emily O'Heir BS, 1,29 Xilma Ortiz-Gonzalez MD, PhD, 30 Marta Pacio-Miguez MS, 31 María Palomares-Bralo MSc, PhD, 31…”
mentioning
confidence: 99%
“…To date, approximately 28 reported cases with 12p13.33 microdeletion have been described and are associated with DD/ID and various neuropsychiatric manifestations ( Table 1 ). In these cases [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ], the phenotypic features were variable and indistinct, maybe due to the size of the deleted segment. However, there seems to be no correlation between the size of the deleted size and the severity of the reported clinical phenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…The Cav1.2 channel plays a part in neurotransmitter release, synaptogenesis, and neuronal excitability; therefore, mutation of CACNA1C is a possible cause of neuropsychiatric disorders [ 33 ]. Recently, the CACNA1C haploinsufficiency was reported to be responsible for the common features of interstitial 12p13.33 deletion carriers [ 23 ]. Furthermore, rs1006737 or the CACNA1C and rs1344706 ZNF804A were commonly associated with schizophrenia and bipolar disorder, and recently with brain phenotypes.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations